neoplasm detection in upper GI
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients who plan to undergo upper gastrointestinal endoscopy and who meet one of following 1) Patients who have history of gastrointestinal cancer (which included oral cavity, larynx, pharynx) 2) Patients whose endoscopy is performed for the present gastrointestinal cancer (which included oral cavity, larynx,pharynx) 3) Patients who have history of chemotherapy or radiotherapy 4)Patients who have history of surgical esophageal or gastric resection.
Exclusion criteria
Exclusion criteria: 1)Patients taking medicines which cause the trouble in obtaining a biopsy tissue 2)Patients who have trouble in undergoing endoscopy 3)Patients with dementia or with disctuebance of consciousness 4)Patients has determined that inappropriate by principal investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary endpoint was the percentage of patients diagnosed as having a neoplastic lesion in the pharynx, esophagus, or stomach using each of WLI and LCI in the first examination. | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary endpoints were the percentages of patients diagnosed,using WLI and LCI, as having a neoplastic lesion stratified by location,size or morphology of the lesions or diagnostic confirmation in the first examination as well as the percentage of patients diagnosed, using WLI and LCI,as having neoplastic lesions or adverse events in the second examination. | — |
Countries
Japan
Contacts
National Hospital Organization Hakodate National Hospital gastroenterology